Sort
23,748 grants matching “melanoma”
MELANOMA ASSOCIATED T AND DC DYSFUNCTION AND DEATH
$296,550University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA
CD24 in Cancer Resistance and Immunotherapy
$296,549Yang Liu · Children'S Research Institute · R01 · FY2013 · CA
Genome-wide association study of cutaneous squamous cell carcinoma
$296,540Maryam Mandana Asgari · Kaiser Foundation Research Institute · R01 · FY2013 · CA
Engineered T Cell Therapy for Melanoma
$296,514Robert H Vonderheide · Wistar Institute · P50 · FY2014 · CA
Subcellular/Cell Cycle Boron-Delivery Studies of Unnatural Amino Acids by SIMS
$296,477Subhash Chandra · Cornell University · R01 · FY2010 · CA
Vaccines to promote Tc-1-based targeting of tumor stroma
$296,440Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · CA
Vaccines to promote Tc-1-based targeting of tumor stroma
$296,440Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Regulatory T Cells and Toll-Like Receptor Signaling in Lymphoma Therapy
$296,411Wang Rongfu · Baylor College Of Medicine · P50 · FY2010 · CA
Regulation of one carbon metabolism and epigenetics by SIRT5
$296,403David Benner Lombard · University Of Michigan At Ann Arbor · R01 · FY2018 · GM
Biospecimen and Pathology Core
$296,400Xiaowei Xu · Wistar Institute · P50 · FY2024 · CA
Mechanism of ECM regulation of actin nucleation during morphogenesis.
$296,400Martha C. Soto · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2009 · GM
A novel immuno-oncolytic viral therapy for the treatment of non-small cell lung carcinoma
$296,257Stephen H Thorne · Western Oncolytics, Ltd · R44 · FY2019 · CA
Melanoma Pathogenesis
$296,222Linda Titus-Ernstoff · Dartmouth College · R01 · FY2006 · CA
Combining targeted radionuclide therapy with a localized in situ vaccine to overcome immune suppression in the tumor microenvironment and augment T cell responses
$296,214Paul M Sondel · University Of Wisconsin-Madison · P01 · FY2024 · CA
Resistance to apoptosis in clinical melanoma gene therapy
$296,171Ali Jazirehi · University Of California Los Angeles · R21 · FY2012 · CA
Therapy of Melanoma with Antigen Specific T Cell Clones
$296,161Fred Hutchinson Cancer Research Center · R21 · FY2001 · CA
The role of Mc1r in melanocytic UV-induced DNA damage and repair responses
$296,160John A Dorazio · University Of Kentucky · R01 · FY2011 · CA
The role of Mc1r in melanocytic UV-induced DNA damage and repair responses
$296,160John A Dorazio · University Of Kentucky · R01 · FY2012 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM
$296,094Evanston Northwestern Healthcare Res Ins · U10 · FY2000 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$296,063Johns Hopkins University · U10 · FY2000 · CA
Mechanisms of Resistance to Radio Inducible Gene Therapy
$296,039Ralph R Weichselbaum · University Of Chicago · R01 · FY2006 · CA
New Proteomic Technologies for the Analysis of Tyrosine Kinase Signaling Pathways
$296,039W. Andy Tao · Purdue University · R01 · FY2014 · GM
Biomarker Discovery for the Classification of Melanoma
$295,929Boris C Bastian · University Of California, San Francisco · R01 · FY2011 · CA
New Target Antigens for Prostate Cancer Immunotherapy
$295,926Vaccinex, Inc. · R43 · FY2005 · CA
Understanding resistance in the HER2-HER3 tumor drive
$295,885Mark M Moasser · University Of California, San Francisco · R01 · FY2013 · CA